An inducer of NKCF (NK cytotoxic factor) release: localization on target-cell membrane and initial characterization.
Natural killer (NK) cells are probably involved in the elimination of virus-infected cells and of certain tumor cells. NK cell-mediated cytotoxicity (NK-CMC) was extensively studied and was found to consist of several steps. Following recognition and conjugation between the effector and the target cell, the latter one induces release of NK cytotoxic factor (NKCF) from the effector cells. The NKCF binds to the target cell which is subsequently killed. None of the molecules involved in these steps was completely characterized. In the present study it is demonstrated that isolated membranes of target cells can effectively induce the release of NKCF. Furthermore, the activity of such isolated membranes was found to be modulated by interferon (IFN) treatment of the cells prior to membrane isolation. It was therefore concluded that an NKCF-inducing structure (NKIS) is present on plasma membranes and is distinct from the NK-recognition structure. Similarly, the sensitivity to NK-CMC could be transferred from sensitive cells to IFN-gamma-treated (NK-resistant) cells by membrane fusion with the aid of Sendai virus envelope glycoproteins. It is proposed that transfer of NKIS is responsible for the acquired sensitivity to NK-CMC. In addition, it is shown that NKIS activity was recovered following membrane solubilization and reconstitution. Its level on cell surface was modulated by treatment of cells with tunicamycin, thus indicating that NKIS was probably a cell surface glycoprotein.
Reiter
Z
Z
Department of Molecular Genetics and Virology, Weizmann Institute of Science, Rehovot, Israel.
Loyter
A
A
Nussbaum
O
O
Rubinstein
M
M
D002462:Cell Membrane / Q000737:chemistry* / Q000187:drug effects; D003602:Cytotoxicity, Immunologic / Q000276:immunology; D006801:Humans; D007372:Interferons / Q000494:pharmacology*; D007694:Killer Cells, Natural / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism; D055646:Killer Factors, Yeast; D008561:Membrane Fusion; D008565:Membrane Proteins / Q000737:chemistry* / Q000187:drug effects / Q000302:isolation & purification; D010222:Parainfluenza Virus 1, Human; D014176:Protein Biosynthesis; D011506:Proteins / Q000737:chemistry / Q000187:drug effects*
D055646:Killer Factors, Yeast; D008565:Membrane Proteins; D011506:Proteins; D007372:Interferons